# Altered Bcl-2/Caspase signaling and hypoxia-induced apoptosis in primary human aniridia limbal stromal cells, in CoCl2 mediated hypoxic stress, in vitro

**Authors:** Shanhe Liu, Shuailin Li, Shao-Lun Hsu, Fabian N. Fries, Zhen Li, Swarnali Kundu, Berthold Seitz, Maryam Amini, Shweta Suiwal, Julia Zimmermann, Simon Trusen, Tanja Stachon, Nóra Szentmáry

PMC · DOI: 10.1371/journal.pone.0328157 · PLOS One · 2025-07-10

## TL;DR

Aniridia limbal stromal cells show higher apoptosis and altered Bcl-2/Caspase signaling under hypoxic stress compared to healthy cells.

## Contribution

This study identifies specific gene and protein expression changes in aniridia limbal cells under hypoxia, offering insights into disease mechanisms.

## Key findings

- AN-LSCs showed significantly higher apoptosis rates than healthy LSCs under hypoxic stress.
- CoCl2 treatment increased apoptosis in AN-LSCs and altered expression of Bcl-2, Caspase, and CDKN1B.
- TNF-α protein levels in supernatant increased in AN-LSCs under hypoxia.

## Abstract

The aim of this study was to investigate apoptosis in primary aniridia limbal stromal cells (LSCs) and to assess changes in the expression of genes and proteins associated with the apoptotic pathway in response to cobalt chloride (CoCl2)-induced hypoxic stress, in vitro.

Primary human limbal stromal cells were isolated from the limbal region of both aniridia (AN-LSCs; n = 8) and healthy (LSCs; n = 8) donors. The cells were treated with 0 µM, 50 µM, and 75 µM CoCl2 for 48 hours. Apoptosis in each group was assessed by Flow cytometry (FC). The expression levels of apoptosis-related genes, including CASP 3/7/8/9/10, BCL2, BID, BAX, CDKN1A (p21), CDKN1B (p27), TNFα, XIAP, and BIRC5 (Survivin), were measured by qPCR. Protein level of these markers was analyzed by FC. TNFα protein expression in the supernatant was quantified using ELISA.

Flow cytometry analysis revealed a significantly higher apoptosis rate in AN-LSCs compared to LSCs (p < 0.0001). In AN-LSCs, treatment with 75 µM CoCl₂ further increased the apoptosis rate compared to untreated AN-LSCs (p = 0.047). BCL2 mRNA levels (p = 0.0291), Caspase-8 (p = 0.0341), Caspase-10 (p = 0.0085), Bcl-2 (p = 0.0014), XIAP (p = 0.0003) and Survivin (p = 0.0074) protein levels were significantly higher in LSCs than in AN-LSCs. Conversely, Caspase-3 (p = 0.0366), Caspase-9 (p = 0.0354), p21 (p = 0.0003), and p27 (p = 0.0164) protein levels were significantly higher in AN-LSCs than in LSCs. In LSCs, exposure to 75 µM CoCl₂ led to a reduction in BCL2 mRNA (p = 0.0102) and protein levels (p = 0.0484), accompanied by an increase in CDKN1B mRNA level (p = 0.0265). In AN-LSCs, 75 µM CoCl₂ treatment resulted in a decrease in CASP3 (p = 0.049), CASP7 (p = 0.041) and BCL2 (p = 0.0218) mRNA and Bcl-2 protein levels (p = 0.0405) and an increase of TNF-α protein levels in the cell culture supernatant (p = 0.0251).

The apoptosis rate of LSCs from patients with congenital aniridia is higher than that of the control group, accompanied by alterations in multiple apoptosis-related markers. Additionally, CoCl₂-induced hypoxic stress further increases apoptosis in AN-LSCs and leads to changes in the expression of Caspase 3, Caspase 7, Bcl-2, and CDKN1B (p27). Further research is needed to elucidate the potential therapeutic targets in AAK, with the aim of preventing or slowing the progression of aniridia-associated keratopathy.

## Linked entities

- **Genes:** CASP3 (caspase 3) [NCBI Gene 836], CASP7 (caspase 7) [NCBI Gene 840], CASP8 (caspase 8) [NCBI Gene 841], CASP9 (caspase 9) [NCBI Gene 842], CASP10 (caspase 10) [NCBI Gene 843], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596], BID (BH3 interacting domain death agonist) [NCBI Gene 637], BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581], CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026], CDKN1B (cyclin dependent kinase inhibitor 1B) [NCBI Gene 1027], TNF (tumor necrosis factor) [NCBI Gene 7124], XIAP (X-linked inhibitor of apoptosis) [NCBI Gene 331], BIRC5 (baculoviral IAP repeat containing 5) [NCBI Gene 332]
- **Proteins:** casp8 (caspase 8, apoptosis-related cysteine peptidase), casp10.L (caspase 10 L homeolog), BCL2 (BCL2 apoptosis regulator), XIAP (X-linked inhibitor of apoptosis), birc5a (baculoviral IAP repeat containing 5a), Casp3 (caspase 3), Casp9 (caspase 9), CDKN1A (cyclin dependent kinase inhibitor 1A), IFI27 (interferon alpha inducible protein 27), TNF (tumor necrosis factor)
- **Chemicals:** CoCl2 (PubChem CID 6371)
- **Diseases:** aniridia (MONDO:0019172)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** XIAP (X-linked inhibitor of apoptosis) [NCBI Gene 331] {aka API3, BIRC4, IAP-3, ILP1, MIHA, XLP2}, DCTN6 (dynactin subunit 6) [NCBI Gene 10671] {aka WS-3, WS3, p27}, CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026] {aka CAP20, CDKN1, CIP1, MDA-6, P21, SDI1}, CDKN1B (cyclin dependent kinase inhibitor 1B) [NCBI Gene 1027] {aka CDKN4, KIP1, MEN1B, MEN4, P27KIP1}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, BIRC5 (baculoviral IAP repeat containing 5) [NCBI Gene 332] {aka API4, EPR-1}, CASP7 (caspase 7) [NCBI Gene 840] {aka CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3}, CASP9 (caspase 9) [NCBI Gene 842] {aka APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56}, CASP8 (caspase 8) [NCBI Gene 841] {aka ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, CASP10 (caspase 10) [NCBI Gene 843] {aka ALPS2, FLICE-2, FLICE2, MCH4}, BID (BH3 interacting domain death agonist) [NCBI Gene 637] {aka FP497}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** hypoxia (MESH:D000860), keratopathy (MESH:C562399), aniridia (MESH:D015783), AN-LSCs (MESH:D000092423), hypoxic (MESH:D002534)
- **Chemicals:** CoCl2 (MESH:C018021)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12244546/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12244546/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12244546/full.md

---
Source: https://tomesphere.com/paper/PMC12244546